307 related articles for article (PubMed ID: 1981306)
1. Overview. Purinergic mechanisms.
Burnstock G
Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306
[TBL] [Abstract][Full Text] [Related]
2. P1- and P2-purinoceptor subtypes--an update.
Kennedy C
Arch Int Pharmacodyn Ther; 1990; 303():30-50. PubMed ID: 2196860
[TBL] [Abstract][Full Text] [Related]
3. Subtypes of P2-purinoceptors. Studies using analogues of ATP.
Cusack NJ; Hourani SM
Ann N Y Acad Sci; 1990; 603():172-81. PubMed ID: 2291519
[TBL] [Abstract][Full Text] [Related]
4. Purinoceptors: are there families of P2X and P2Y purinoceptors?
Abbracchio MP; Burnstock G
Pharmacol Ther; 1994; 64(3):445-75. PubMed ID: 7724657
[TBL] [Abstract][Full Text] [Related]
5. Purinergic signalling: past, present and future.
Burnstock G
Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040
[TBL] [Abstract][Full Text] [Related]
6. Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.
Hoyle CH; Edwards GA
Br J Pharmacol; 1992 Oct; 107(2):367-74. PubMed ID: 1422586
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling--an overview.
Burnstock G
Novartis Found Symp; 2006; 276():26-48; discussion 48-57, 275-81. PubMed ID: 16805422
[TBL] [Abstract][Full Text] [Related]
8. Evidence for two distinct P2-purinoceptors subserving contraction of the rat anococcygeus smooth muscle.
Najbar AT; Li CG; Rand MJ
Br J Pharmacol; 1996 Jun; 118(3):537-42. PubMed ID: 8762075
[TBL] [Abstract][Full Text] [Related]
9. Purinergic signalling: pathophysiology and therapeutic potential.
Burnstock G
Keio J Med; 2013; 62(3):63-73. PubMed ID: 24067872
[TBL] [Abstract][Full Text] [Related]
10. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
11. Roles of P2-purinoceptors in the cardiovascular system.
Ralevic V; Burnstock G
Circulation; 1991 Jul; 84(1):1-14. PubMed ID: 1647896
[TBL] [Abstract][Full Text] [Related]
12. Current state of purinoceptor research.
Burnstock G
Pharm Acta Helv; 1995 Mar; 69(4):231-42. PubMed ID: 7651967
[TBL] [Abstract][Full Text] [Related]
13. Purinoceptors mediating relaxation and spasm in the rat gastric fundus.
Matharu MS; Hollingsworth M
Br J Pharmacol; 1992 Jun; 106(2):395-403. PubMed ID: 1393267
[TBL] [Abstract][Full Text] [Related]
14. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms.
Rump LC; Oberhauser V; von Kügelgen I
Kidney Int; 1998 Aug; 54(2):473-81. PubMed ID: 9690214
[TBL] [Abstract][Full Text] [Related]
15. Blood cells: an historical account of the roles of purinergic signalling.
Burnstock G
Purinergic Signal; 2015 Dec; 11(4):411-34. PubMed ID: 26260710
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological effects and metabolism of extracellular ATP].
Nakazawa M
Nihon Yakurigaku Zasshi; 1991 Sep; 98(3):235-43. PubMed ID: 1743602
[TBL] [Abstract][Full Text] [Related]
17. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
Palea S; Corsi M; Pietra C; Artibani W; Calpista A; Gaviraghi G; Trist DG
J Pharmacol Exp Ther; 1994 Apr; 269(1):193-7. PubMed ID: 8169824
[TBL] [Abstract][Full Text] [Related]
18. Purinergic signalling.
Burnstock G
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S172-81. PubMed ID: 16402102
[TBL] [Abstract][Full Text] [Related]
19. Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance.
Verkhratsky A; Burnstock G
Bioessays; 2014 Jul; 36(7):697-705. PubMed ID: 24782352
[TBL] [Abstract][Full Text] [Related]
20. Introduction to Purinergic Signaling.
Burnstock G
Methods Mol Biol; 2020; 2041():1-15. PubMed ID: 31646477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
